Cargando…
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
Virus-like particles (VLPs) are a versatile, safe, and highly immunogenic vaccine platform. Recently, there are developmental vaccines targeting SARS-CoV-2, the causative agent of COVID-19. The COVID-19 pandemic affected humanity worldwide, bringing out incomputable human and financial losses. The r...
Autores principales: | Prates-Syed, Wasim A., Chaves, Lorena C. S., Crema, Karin P., Vuitika, Larissa, Lira, Aline, Côrtes, Nelson, Kersten, Victor, Guimarães, Francisco E. G., Sadraeian, Mohammad, Barroso da Silva, Fernando L., Cabral-Marques, Otávio, Barbuto, José A. M., Russo, Momtchilo, Câmara, Niels O. S., Cabral-Miranda, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708688/ https://www.ncbi.nlm.nih.gov/pubmed/34960155 http://dx.doi.org/10.3390/vaccines9121409 |
Ejemplares similares
-
Vaccines against Emerging and Neglected Infectious Diseases: An Overview
por: Vuitika, Larissa, et al.
Publicado: (2022) -
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2018) -
Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement
por: Schmidt, Frederik L., et al.
Publicado: (2021) -
VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases
por: Queiroz, Aline Maria Vasconcelos, et al.
Publicado: (2021) -
Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery
por: Sánchez-Sánchez, Lorena, et al.
Publicado: (2015)